Collingswood-based medical communications BioCentric was recently acquired by health care public relations and marketing company JPA Health. The deal, which closed May 14, will allow JPA to support clients comprehensively in the years to come, JPA CEO Carrie Jones said.
Financial details of the deal were not disclosed.
BioCentric will serve as JPA Health’s medical communications and learning experiences arm, leveraging its innovative serious games and gamification approach to enhance engagements, capture meaningful insights and drive positive behavior change.
Sherine Aly, who founded BioCentric in 2001, will continue to lead the division.
“Joining JPA Health allows us to elevate our work to new heights. Our shared commitment to improving lives by connecting health care stakeholders and leveraging the latest technological innovations will unlock powerful and creative synergies,” Aly said. “Together, we can now offer our clients end-to-end solutions that make a real difference in patients’ lives.”
This acquisition follows JPA Health’s purchase of True North Solutions in September 2023, further expanding the agency’s capabilities in predictive analytics, artificial intelligence and natural language processing. With the integration of True North Solutions and BioCentric, JPA Health will continue to build on its mission to provide comprehensive, data-driven and high-impact services to clients across the life sciences, public health, one health and federal government sectors.
The combined agency has more than 120 employees across offices in the U.S. and Europe, offering a synergistic suite of services that includes corporate communications, brand marketing, patient engagement and scientific storytelling. This integration is rooted in the shared values and vision of both organizations, deeply committed to advancing medicine and improving health outcomes.
BioCentric’s team of 27 will be integrated into JPA, creating a combined network of more than 120 employees across offices in the U.S. and Europe. Its suite of services will include corporate communications, brand marketing, patient engagement and scientific storytelling.
